Showing results (181-190 of 205) with videos related to

Sort By:
Pageof 21
Hepatology (Baltimore, Md.)|April 9, 2008
Beta-catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse developmentXinping Tan, Youzhong Yuan, Gang Zeng, et al.
Hepatology (Baltimore, Md.)|January 30, 2007
Activation of LXRs prevents bile acid toxicity and cholestasis in female miceHirdesh Uppal, Simrat P S Saini, Antonio Moschetta, et al.
Nutrients|August 6, 2020
Sulforaphane Diminishes the Formation of Mammary Tumors in Rats Exposed to 17β-EstradiolDushani L Palliyaguru, Li Yang, Dionysios V Chartoumpekis, et al.
Hepatology (Baltimore, Md.)|January 29, 2011
Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzeneShashikiran Donthamsetty, Vishakha S Bhave, Corrine S Kliment, et al.
Hepatology (Baltimore, Md.)|May 17, 2011
Hepatocyte proliferation and hepatomegaly induced by phenobarbital and 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene is suppressed in hepatocyte-targeted glypican 3 transgenic miceChih-Wen Lin, Wendy M Mars, Shirish Paranjpe, et al.
Nature Medicine|August 21, 2007
Lack of Fas antagonism by Met in human fatty liver diseaseChunbin Zou, Jihong Ma, Xue Wang, et al.
Human Pathology|July 17, 2004
Webcasting pathology department conferences in a geographically distributed medical centerYukako Yagi, Ishtiaque Ahmed, William Gross, et al.
Biochemical and Biophysical Research Communications|March 1, 2000
Serum-free, long-term cultures of human hepatocytes: maintenance of cell morphology, transcription factors, and liver-specific functionsD Runge, D M Runge, D Jäger, et al.
Biochemical and Biophysical Research Communications|June 30, 2000
Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytesD Runge, C Köhler, V E Kostrubsky, et al.
The American Journal of Pathology|May 6, 2019
A Noncanonical Role for Plasminogen Activator Inhibitor Type 1 in Obesity-Induced DiabetesGina M Coudriet, John Stoops, Anne V Orr, et al.
Pageof 21